Sung, H., et al. (2021). Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249.

Google Scholar 

Eliyatkin, N., et al. (2015). Molecular classification of breast carcinoma: From traditional, old-fashioned way to a new age, and a new way. Journal of Breast Health, 11(2), 59–66.

PubMed  PubMed Central  Article  Google Scholar 

Harbeck, N., & Gnant, M. (2017). Breast cancer. Lancet, 389(10074), 1134–1150.

PubMed  Article  Google Scholar 

Loibl, S., & Gianni, L. (2017). HER2-positive breast cancer. Lancet, 389(10087), 2415–2429.

CAS  PubMed  Article  Google Scholar 

Marra, A., et al. (2020). Practical classification of triple-negative breast cancer: Intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies. NPJ Breast Cancer, 6(1), 54.

Chia, K., et al. (2015). Targeting the androgen receptor in breast cancer. Current Oncology Reports, 17(2), 4.

PubMed  Article  CAS  Google Scholar 

Kim, Y., Jae, E., & Yoon, M. (2015). Influence of androgen receptor expression on the survival outcomes in breast cancer: A meta-analysis. Journal of Breast Cancer, 18(2), 134.

PubMed  PubMed Central  Article  Google Scholar 

Choi, J. E., et al. (2015). Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer. Annals of Surgical Oncology, 22(1), 82–89.

PubMed  Article  Google Scholar 

Li, Z.-H., et al. (2016). Luminal B breast cancer: Patterns of recurrence and clinical outcome. Oncotarget, 7(40), 65024–65033.

PubMed  PubMed Central  Article  Google Scholar 

Higgins, M. J., & Stearns, V. (2009). Understanding resistance to tamoxifen in hormone receptor-positive breast cancer. Clinical Chemistry, 55(8), 1453–1455.

CAS  PubMed  Article  Google Scholar 

Arteaga, C. L., et al. (2012). Treatment of HER2-positive breast cancer: Current status and future perspectives. Nature Reviews Clinical Oncology, 9(1), 16–32.

CAS  Article  Google Scholar 

Landry, I., Sumbly, V., & Vest, M. (2022). Advancements in the treatment of triple-negative breast cancer: A narrative review of the literature. Cureus, 14(2), e21970.

Rakha, E. A., Reis-Filho, J. S., & Ellis, I. O. (2008). Basal-like breast cancer: A critical review. Journal of Clinical Oncology, 26(15), 2568–2581.

PubMed  Article  Google Scholar 

Perou, C. M. (2010). Molecular stratification of triple-negative breast cancers. The Oncologist, 15(S5), 39–48.

CAS  PubMed  Article  Google Scholar 

Fougner, C., et al. (2020). Re-definition of claudin-low as a breast cancer phenotype. Nature Communications, 11(1), 1787.

Garrido-Castro, A. C., Lin, N. U., & Polyak, K. (2019). Insights into Molecular Classifications of triple-negative breast cancer: Improving patient selection for treatment. Cancer Discovery, 9(2), 176–198.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Foulkes, W. D., et al. (2003). Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. Journal of the National Cancer Institute, 95(19), 1482–1485.

CAS  PubMed  Article  Google Scholar 

Denkert, C., et al. (2017). Molecular alterations in triple-negative breast cancer—The road to new treatment strategies. The Lancet, 389(10087), 2430–2442.

CAS  Article  Google Scholar 

Hales, C. M., et al. (2020). Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief, 360, 1–8.

Google Scholar 

Diet, nutrition, physical activity and breast cancer. Diet, Nutrition, Physical Activity and Cancer: A Global Perspective 2018

Bhardwaj, P., et al. (2019). Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression. The Journal of Steroid Biochemistry and Molecular Biology, 189, 161–170.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Lohmann, A. E., et al. (2021). Association of obesity with breast cancer outcome in relation to cancer subtypes: A meta-analysis. jnci: Journal of the National Cancer Institute, 113(11), 1465–1475.

PubMed  PubMed Central  Article  Google Scholar 

Chen, Y., et al. (2017). Body mass index had different effects on premenopausal and postmenopausal breast cancer risks: A dose-response meta-analysis with 3,318,796 subjects from 31 cohort studies. BMC Public Health, 17(1), 936.

PubMed  PubMed Central  Article  Google Scholar 

White, A. J., et al. (2015). Overall and central adiposity and breast cancer risk in the Sister Study. Cancer, 121(20), 3700–3708.

PubMed  Article  Google Scholar 

Neuhouser, M. L., et al. (2015). Overweight, obesity, and postmenopausal invasive breast cancer risk. JAMA Oncology, 1(5), 611.

PubMed  PubMed Central  Article  Google Scholar 

Modi, N.D., et al. (2021). The obesity paradox in early and advanced HER2 positive breast cancer: Pooled analysis of clinical trial data. NPJ Breast Cancer, 7(1), 30.

Widschwendter, P., et al. (2015). The influence of obesity on survival in early, high-risk breast cancer: Results from the randomized SUCCESS A trial. Breast Cancer Research, 17(1), 129.

Mazzarella, L., et al. (2013). Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients. European Journal of Cancer, 49(17), 3588–3597.

CAS  PubMed  Article  Google Scholar 

Shu, X., et al. (2019). Associations of obesity and circulating insulin and glucose with breast cancer risk: A Mendelian randomization analysis. International Journal of Epidemiology, 48(3), 795–806.

PubMed  Article  Google Scholar 

Zhao, C., et al. (2021). Current landscape: The Mechanism and therapeutic impact of obesity for breast cancer. Frontiers in Oncology, 11, 704893.

PubMed  PubMed Central  Article  Google Scholar 

Sabol, R.A., et al. (2019). Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models. Breast Cancer Research, 21(1), 67.

Desantis, C. E., et al. (2019). Breast cancer statistics, 2019. CA: A Cancer Journal for Clinicians, 69(6), 438–451.

Google Scholar 

Barone, I., et al. (2020). The weight of obesity in breast cancer progression and metastasis: Clinical and molecular perspectives. Seminars in Cancer Biology, 60, 274–284.

CAS  PubMed  Article  Google Scholar 

Barkan, D., & Green, J. E. (2011). An In Vitro System to study tumor dormancy and the switch to metastatic growth. Journal of Visualized Experiments, (54), 2914.

Kaushik, S., Pickup, M. W., & Weaver, V. M. (2016). From transformation to metastasis: Deconstructing the extracellular matrix in breast cancer. Cancer and Metastasis Reviews, 35(4), 655–667.

CAS  PubMed  Article  Google Scholar 

Haakinson, D. J., et al. (2012). The Impact of Obesity on Breast Cancer: A Retrospective Review., 19(9), 3012–3018.

Google Scholar 

Bergom, C., et al. (2016). Association of locoregional control with high body mass index in women undergoing breast conservation therapy for early-stage breast cancer. International Journal of Radiation Oncology Biology Physics, 96(1), 65–71.

PubMed  Article  Google Scholar 

Petrelli, F., et al. (2021). Association of obesity with survival outcomes in patients with cancer: A systematic review and meta-analysis. JAMA Network Open, 4(3), e213520.

PubMed  PubMed Central  Article  Google Scholar 

Ewertz, M., et al. (2011). Effect of obesity on prognosis after early-stage breast cancer. Journal of Clinical Oncology, 29(1), 25–31.

PubMed  Article  Google Scholar 

Buono, G., et al. (2020). Metabolic syndrome and early stage breast cancer outcome: Results from a prospective observational study. Breast Cancer Research and Treatment, 182(2), 401–409.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Lee, K., et al., (2019). The impact of obesity on breast cancer diagnosis and treatment. Current Oncology Reports, 21(5), 41.

Bousquenaud, M., Fico, F., Solinas, G. et al. (2018). Obesity promotes the expansion of metastasis-initiating cells in breast cancer. Breast Cancer Research, 20(1), 104.

O’Flanagan, C. H., et al. (2017). Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer. NPJ Breast Cancer, 3, 26.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Evangelista, G. C. M., S. P., Soares, S. M. A., Barros, L. R. C., Xavier, F. H. D. C., Abdo, L. M., Gualberto, A. C. M., Macedo, G. C., Clavijo-Salomon, M. A., & Gameiro, J. (2019). 4T1 Mammary Carcinoma Colonization of metastatic niches is accelerated by obesity. Frontiers Oncology, 9, 685.

Osman, M. A., & Hennessy, B. T. (2015). Obesity Correlation with metastases development and response to first-line metastatic chemotherapy in breast cancer. Clinical Medicine Insights: Oncology, 9, CMO.S32812.

Article  Google Scholar 

Catalano, S., et al. (2015). A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo. Journal of Cellular and Molecular Medicine, 19(5), 1122–1132.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Naylor, C., & Petri, W. A., Jr. (2016). Leptin regulation of immune responses. Trends in Molecular Medicine, 22(2), 88–98.

CAS  PubMed  Article  Google Scholar 

Bowers, L. W., et al. (2018). Leptin signaling mediates obesity-associated csc enrichment and EMT in preclinical TNBC models. Molecular Cancer Research, 16(5), 869–879.

CAS  PubMed  Article  Google Scholar 

Hillers-Ziemer, L. E., et al. (2021). Obesity-activated lung stromal cells promote myeloid lineage cell accumulation and breast cancer metastasis. Cancers, 13(5), 1005.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Lapeire, L., et al. (2015). When fat becomes an ally of the enemy: Adipose tissue as collaborator in human breast cancer. Horm Mol Biol Clin Investig, 23(1), 21–38.

CAS  PubMed  Google Scholar 

Santander, A., et al. (2015). Paracrine Interactions between adipocytes and tumor cells recruit and modify macrophages to the mammary tumor microenvironment: The role of obesity and inflammation in breast adipose tissue. Cancers, 7(1), 143–178.

CAS